RECRUITING

Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The researchers are trying to find out more about Gastric Antral Vascular Ectasia (GAVE). This is a condition that affects the blood vessels in the stomach, leading to their enlargement and possible bleeding. It can also cause symptoms such as abdominal pain and nausea. By participating in this study, you will help us learn how often these symptoms occur and how they relate to stomach functioning.

Official Title

Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias

Quick Facts

Study Start:2024-03-22
Study Completion:2026-09-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06306963

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:19 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients \>18 years of age with endoscopic evidence of Gastric Antral Vascular Ectasia.
  2. * Willingness to participate in the study
  3. * Capacity to provide informed consent.
  4. * No evidence of organic, systemic, or metabolic disease (e.g. diabetes mellitus) to explain the symptoms on routine investigations
  1. * Patients with active bleeding.
  2. * Patients with severe decompensated liver disease.
  3. * Patients with chronic kidney disease.
  4. * Presence of other diseases (structural or metabolic) which could interfere with interpretation of the study results.
  5. * Pregnant or lactating women due to radiation exposure.

Contacts and Locations

Study Contact

Taylor N Hines
CONTACT
507-538-9959
hines.taylor@mayo.edu

Principal Investigator

Xiao Jing Wang, MD
PRINCIPAL_INVESTIGATOR
Mayo Clinic

Study Locations (Sites)

Mayo Clinic
Rochester, Minnesota, 55905
United States

Collaborators and Investigators

Sponsor: Mayo Clinic

  • Xiao Jing Wang, MD, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-03-22
Study Completion Date2026-09-01

Study Record Updates

Study Start Date2024-03-22
Study Completion Date2026-09-01

Terms related to this study

Additional Relevant MeSH Terms

  • Gastric Antral Vascular Ectasia
  • Cirrhosis